|1.||Chaves, P: 2 articles (11/2014 - 01/2002)|
|2.||Servin, A L: 2 articles (05/2001 - 10/2000)|
|3.||Peiffer, I: 2 articles (05/2001 - 10/2000)|
|4.||Bernet-Camard, M F: 2 articles (05/2001 - 10/2000)|
|5.||Wu, Zaining: 1 article (02/2015)|
|6.||Marcadier, Julien L: 1 article (02/2015)|
|7.||Geraghty, Michael T: 1 article (02/2015)|
|8.||McIntyre, Adam D: 1 article (02/2015)|
|9.||Hegele, Robert A: 1 article (02/2015)|
|10.||Lines, Matthew A: 1 article (02/2015)|
05/01/1991 - "This study shows that the expression of enzymatically active sucrase-isomaltase is a ubiquitous property of primary and metastatic colon adenocarcinoma. "
11/01/1996 - "Sucrose isomaltase analysis revealed positive staining in 55% (22/40) of the BAs and 44% (11/25) of the cardia adenocarcinomas. "
11/01/1996 - "Detection of Barrett's adenocarcinoma of the gastric cardia with sucrase isomaltase and p53."
12/15/1991 - "Clonal analysis of sucrase-isomaltase expression in the human colon adenocarcinoma Caco-2 cells."
05/01/1991 - "Thus, the specificity and ubiquity of sucrase-isomaltase expression in adenocarcinomas of the colon can be exploited to improve the clinical management of this disease. "
|2.||Colonic Neoplasms (Colon Cancer)
07/04/2008 - "We report a novel mechanistic role of CHOP in the inhibition of Wnt/TCF signaling and stimulation of c-Jun and sucrase-isomaltase reporter activity in intestinal colon cancer cells. "
08/01/1992 - "To gain further insight on the mosaic expression of specific functional intestinal markers (such as sucrase-isomaltase) in postconfluent Caco-2 cells, a human colon cancer cell line unique in its property to differentiate in vitro into a mature enterocyte-like cell type, a comparative study was undertaken to examine the morphological and functional differentiation of Caco-2 cells at various culture stages. "
08/01/1992 - "Southern blotting, sequencing and mRNA studies indicate that the structures of the sucrase-isomaltase gene and its mRNA are unaltered in the two human colon cancer cell lines Caco-2 and HT-29 in comparison with normal human small intestine."
05/05/1988 - "Studies on the regulation of the enterocytic differentiation of the human colon cancer cell line HT-29, which is differentiated in the absence (Glc-) but not in the presence of glucose (Glc+), have recently shown that the post-translational processing of sucrase-isomaltase and particularly its glycosylation vary as a function of cell differentiation (Trugnan G., Rousset, M., Chantret, I., Barbat, A., and Zweibaum, A. "
11/01/1987 - "Sucrase-isomaltase in colon cancers: an example of re-expression of a foetal enzyme with associated blood group antigens."
06/01/1990 - "These results demonstrate that colonic crypt cells and some benign tumor cells synthesize and express at their cell surface a form of sucrase-isomaltase immunologically distinct from that present in the brush borders of small intestinal villose cells."
06/01/1990 - "A panel of monoclonal antibodies specific for sucrase-isomaltase, but differing in their ability to stain the proliferative crypt cells in human jejunum, was used to investigate expression of this enzyme in adult human colon and colonic tumors. "
03/01/1987 - "Similar results were obtained in the corresponding tumors in nude mice: anti-A antibodies in HT-29 and UEA-I in Caco-2 tumors bound to the same apical structures as did anti-sucrase-isomaltase antibodies; sucrase-isomaltase immunoisolated from the tumors bound anti-A antibodies (HT-29) or UEA-I (Caco-2). "
05/01/1991 - "Using a quantitative polymerase chain reaction analysis, this study shows that the amount of sucrase-isomaltase messenger RNA in tumors examined (3.4 x 10(-8) to 3.19 x 10(-7) micrograms/micrograms total RNA) was greater than in adjacent mucosa (0 to 3.4 x 10(-8) micrograms/micrograms total RNA). "
05/01/1991 - "Sucrase-isomaltase messenger RNA was identified in all tumors using reverse transcriptase polymerase chain reaction. "
09/01/1998 - "In the present study, to reinvestigate disaccharidase expression during rotavirus infection, we studied sucrase-isomaltase (SI) in RRV-infected Caco-2 cells. "
09/01/1998 - "Rotavirus infection reduces sucrase-isomaltase expression in human intestinal epithelial cells by perturbing protein targeting and organization of microvillar cytoskeleton."
05/01/1991 - "In addition, all colon carcinoma metastases examined were positive for sucrase-isomaltase. "
08/01/1990 - "Sucrase-isomaltase activity in the polyps was 18.1 +/- 1.8 mU/mg (mean +/- SD); in adjacent carcinoma SI activity was 29.1 +/- 1.8 mU/mg. Adjacent mucosa showed no activity in all cases. "
04/01/1996 - "We have previously shown that glucose can exert a repressive effect on the transcription of the sucrase-isomaltase (SI) gene in the differentiated enterocyte-like human colon carcinoma cell lines HT-29 and Caco-2. "
02/01/1991 - "Immunoelectron microscopy was used to localize the brush border hydrolases sucrase-isomaltase (SI) and dipeptidylpeptidase IV (DPPIV) in the human colon carcinoma cell line Caco-2. "
12/16/1987 - "Finally, glucocorticosteroid treatment of a human colon carcinoma cell line (Caco-2) in vitro or of baby rabbits in vivo leads to a parallel increase of both sucrase and isomaltase activities and of sucrase-isomaltase mRNA. "
|1.||Sucrase (Sucrose alpha-D-Glucohydrolase)
|3.||Messenger RNA (mRNA)
|4.||CD13 Antigens (Alanine Aminopeptidase)
|9.||RNA (Ribonucleic Acid)
|1.||Colonic Pouches (S Pouch)